158 related articles for article (PubMed ID: 12458674)
1. Enhanced permeability of molecular weight markers and poorly bioavailable compounds across Caco-2 cell monolayers using the absorption enhancer, zonula occludens toxin.
Cox DS; Raje S; Gao H; Salama NN; Eddington ND
Pharm Res; 2002 Nov; 19(11):1680-8. PubMed ID: 12458674
[TBL] [Abstract][Full Text] [Related]
2. Enhancing the permeation of marker compounds and enaminone anticonvulsants across Caco-2 monolayers by modulating tight junctions using zonula occludens toxin.
Cox DS; Gao H; Raje S; Scott KR; Eddington ND
Eur J Pharm Biopharm; 2001 Sep; 52(2):145-50. PubMed ID: 11522479
[TBL] [Abstract][Full Text] [Related]
3. Zonula occludens toxin increases the permeability of molecular weight markers and chemotherapeutic agents across the bovine brain microvessel endothelial cells.
Karyekar CS; Fasano A; Raje S; Lu R; Dowling TC; Eddington ND
J Pharm Sci; 2003 Feb; 92(2):414-23. PubMed ID: 12532391
[TBL] [Abstract][Full Text] [Related]
4. Zonula occludens toxin synthetic peptide derivative AT1002 enhances in vitro and in vivo intestinal absorption of low molecular weight heparin.
Motlekar NA; Fasano A; Wachtel MS; Youan BB
J Drug Target; 2006 Jun; 14(5):321-9. PubMed ID: 16882552
[TBL] [Abstract][Full Text] [Related]
5. Effect of the biologically active fragment of zonula occludens toxin, delta G, on the intestinal paracellular transport and oral absorption of mannitol.
Salama NN; Fasano A; Lu R; Eddington ND
Int J Pharm; 2003 Jan; 251(1-2):113-21. PubMed ID: 12527181
[TBL] [Abstract][Full Text] [Related]
6. Effect of the six-mer synthetic peptide (AT1002) fragment of zonula occludens toxin on the intestinal absorption of cyclosporin A.
Song KH; Fasano A; Eddington ND
Int J Pharm; 2008 Mar; 351(1-2):8-14. PubMed ID: 17954018
[TBL] [Abstract][Full Text] [Related]
7. The effect of delta G on the transport and oral absorption of macromolecules.
Salama NN; Fasano A; Thakar M; Eddington ND
J Pharm Sci; 2004 May; 93(5):1310-9. PubMed ID: 15067707
[TBL] [Abstract][Full Text] [Related]
8. Zonula occludens toxin modulates tight junctions through protein kinase C-dependent actin reorganization, in vitro.
Fasano A; Fiorentini C; Donelli G; Uzzau S; Kaper JB; Margaretten K; Ding X; Guandalini S; Comstock L; Goldblum SE
J Clin Invest; 1995 Aug; 96(2):710-20. PubMed ID: 7635964
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the
Pérez-Reytor D; Pavón A; Lopez-Joven C; Ramírez-Araya S; Peña-Varas C; Plaza N; Alegría-Arcos M; Corsini G; Jaña V; Pavez L; Del Pozo T; Bastías R; Blondel CJ; Ramírez D; García K
Front Cell Infect Microbiol; 2020; 10():482. PubMed ID: 33072618
[No Abstract] [Full Text] [Related]
10. Zonula occludens toxin as a new promising adjuvant for mucosal vaccines.
De Magistris MT
Vaccine; 2006 Apr; 24 Suppl 2():S2-60-1. PubMed ID: 16823929
[TBL] [Abstract][Full Text] [Related]
11. [Cloning and expression of Vibrio cholerae zonula occludens toxin (zot) gene in Escherichia coli].
Pisanov RV; Goncharov EK; Monakhova EV; Alekseeva LP; Mishan'kin BN
Mol Gen Mikrobiol Virusol; 2005; (1):28-32. PubMed ID: 15790030
[TBL] [Abstract][Full Text] [Related]
12. The intestinal zonula occludens toxin (ZOT) receptor recognises non-native ZOT conformers and localises to the intercellular contacts.
Lee A; White N; van der Walle CF
FEBS Lett; 2003 Dec; 555(3):638-42. PubMed ID: 14675787
[TBL] [Abstract][Full Text] [Related]
13. Tight junction modulation and biochemical characterisation of the zonula occludens toxin C-and N-termini.
Schmidt E; Kelly SM; van der Walle CF
FEBS Lett; 2007 Jun; 581(16):2974-80. PubMed ID: 17553496
[TBL] [Abstract][Full Text] [Related]
14. Tight junction modulation and its relationship to drug delivery.
Salama NN; Eddington ND; Fasano A
Adv Drug Deliv Rev; 2006 Apr; 58(1):15-28. PubMed ID: 16517003
[TBL] [Abstract][Full Text] [Related]
15. Expression of Vibrio cholerae zonula occludens toxin and analysis of its subcellular localization.
Uzzau S; Cappuccinelli P; Fasano A
Microb Pathog; 1999 Dec; 27(6):377-85. PubMed ID: 10588910
[TBL] [Abstract][Full Text] [Related]
16. Modulation of intestinal tight junctions by Zonula occludens toxin permits enteral administration of insulin and other macromolecules in an animal model.
Fasano A; Uzzau S
J Clin Invest; 1997 Mar; 99(6):1158-64. PubMed ID: 9077522
[TBL] [Abstract][Full Text] [Related]
17. The impact of DeltaG on the oral bioavailability of low bioavailable therapeutic agents.
Salama NN; Fasano A; Thakar M; Eddington ND
J Pharmacol Exp Ther; 2005 Jan; 312(1):199-205. PubMed ID: 15448170
[TBL] [Abstract][Full Text] [Related]
18. Zonula occludens toxin structure-function analysis. Identification of the fragment biologically active on tight junctions and of the zonulin receptor binding domain.
Di Pierro M; Lu R; Uzzau S; Wang W; Margaretten K; Pazzani C; Maimone F; Fasano A
J Biol Chem; 2001 Jun; 276(22):19160-5. PubMed ID: 11278543
[TBL] [Abstract][Full Text] [Related]
19. ZOT-derived peptide and chitosan functionalized nanocarrier for oral delivery of protein drug.
Lee JH; Sahu A; Choi WI; Lee JY; Tae G
Biomaterials; 2016 Oct; 103():160-169. PubMed ID: 27380442
[TBL] [Abstract][Full Text] [Related]
20. A gene for the enterotoxin zonula occludens toxin is present in Vibrio mimicus and Vibrio cholerae O139.
Chowdhury MA; Hill RT; Colwell RR
FEMS Microbiol Lett; 1994 Jun; 119(3):377-80. PubMed ID: 8050719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
